accuracy and reproducibility (mean error -10 %, standard deviation +36%). Blood loss of the order of 400 to 500 ml. can be measured with greater reproducibility (-12%, ±26%).
Although a whole-body counter has previously been applied to clinical problems of blood loss (Price et al., 1964) , the technique has never been evaluated critically. Price et al. calculated wenstrual blood loss against a direct measurement of the 59Fe -ontent of tampons in one case, and thought an error of 2G-40 ml. in losses amounting to 33-59 ml. was likely. Nevertheless it is probably wrong to assume that blood loss occurring clinically can be measured with the same precision as was attained with venesection of patients with polycythaemia. Gastrointestinal or menstrual bleeding may occur erratically and lead to fluctuations in the red cell content of 59Fe and blood volume, both of which cannot be corrected for.
By the above method we are unable to measure reliably blood loss of the order of 100 ml., and an accurate assessment of a single moderately heavy menstrual period is not possible. However, a more accurate measurement is possible if the patient is followed over three or four menstrual cycles.
The ease and simplicity of the technique described here is such that all the studies were carried out on subjects visiting the department as outpatients. The technique is now available in this hospital as a diagnostic service and is being used to study the mechanism of rnaemia in patients with hiatus hernia, ulcerative colitis, and Crohn's disease. Summary A method is described for the measurement of blood loss over periods of up to three months by means of 59Fe and a whole-body counter. Patients with polycythaemia from whom known quantities of blood were removed by venesection were studied to evaluate this technique. The method is sensitive and accurate enough for clinical purposes, and blood loss of more than 700 ml. can be measured with reproducibility of +14%. To illustrate its application to clinical problems, studies of five cases of hypochromic anaemia are described. , 1967, 4, 88-90 The range and variety of plasma expanders and plasma substitutes are constantly increasing, particularly in the case of dextran solutions (Mollison, 1967; Brit. med. 7., 1967 Ltd.) . As a control, tests were also set up with normal saline in place of one of the above substances. All samples of blood were taken from healthy human volunteers into Sequestrene (sodium edetate). The Westergren sedimentation rate of each sample was 2 mm. in the first hour. Three main sets of experiments were then performed. (Table I) .
Five different samples of blood were tested (Tests A-E). Citrate was added to each mixture and the samples were set up in Westergren tubes at room temperature, results being read at the end of one hour. The substitution of plasma or plasma protein solution for saline had no effect on the sedimentation rate ( Table I Roche et al, 1952; Bowman, 1953; Ar-dX Hanser, 1956 ; -Pettofer, 1959; Haynes, 1960) . Surprisingly, dextran 110 produced rouleawr ft*: * readily as dextran 159. The degree of rouleaux f ion i There is a critical level of molecular weight so far as rouleaux formation by dextrans is concerned (Thorsen and Hint, 1950) . Dextrans with an average molecular weight below 60,000 cause no increase in sedimentation rate. As the molecular weight increases above 60,000, red-cell rouleaux formation appears and the sedimentation rate rises progressively.
Macrodex has an average molecular weight of about 70,000. About 10% of the preparation has a mean molecular weight of 108,000 and 9% of 25,800 (Kjellman, 1965 ; Rousell, 1966; Nilsson, 1967) . Hence on average Macrodex is only slightly above the critical molecular weight. Dextran 110 has an average molecular weight of about 110,000. Ten per cent. of the preparation has a mean molecular weight of 194,000, and 8% of 35,000 (Nilsson, 1967) . This is reflected in an increased tendency to cause rouleaux formation and a rise in the erythrocyte sedimentation rate.
Thus from the point of view of effective blood grouping and cross-matching it would seem essential to take blood from a patient for these purposes before administration of dextran 110 or dextran 150. If immediate transfusion before withdrawal of blood is required Macrodex will cause little interference, and plasma or plasma-protein solution no interference, with blood grouping and cross-matching.
Sunumary
Plasma, plasma-protein solution, Macrodex, dextran 110, and dextran 150 were compared for their effect upon red-cell rouleaux formation and erythrocyte sedimentation rate in a series of in vitro experiments.
Plasma and plasma-protein solution do not produce rouleaux formation and have no effect upon the sedimentation rate. Macrodex, in concentrations likely to be found in plasma, does not caused marked rouleaux formation. Therefore administration of these substances before the taking of blood is unlikely to lead to any difficulty in blood grouping and cross-matching.
In contrast, both dextran 110 and dextran 150 produce marked rouleaux formation and a considerable rise in the E.S.R. They are likely to interfere with blood grouping and crossmatching, and should be given to a patient only after blood has been withdrawn.
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